Search research articles
Contact Us
Filters
Showing results (211-220 of 487) with videos related to
Page
of 49
Sort By:
Abdominal Radiology (New York)
|
November 24, 2019
Imaging of acute abdomen in cancer patients
Ajaykumar C Morani, Abdelrahman K Hanafy, Leonardo P Marcal, et al.
Molecular Cancer Therapeutics
|
April 15, 2018
Clinical Next-Generation Sequencing for Precision Oncology in Rare Cancers
Roman Groisberg, David S Hong, Jason Roszik, et al.
BMC Medical Education
|
June 5, 2023
Challenges in diagnosis and biomarker testing for RET-altered lung and thyroid cancer care: an international mixed-method study
Patrice Lazure, Anthony Sireci, Vivek Subbiah, et al.
Journal of Immunotherapy and Precision Oncology
|
April 11, 2025
Pembrolizumab in Patients with Advanced Miscellaneous Rare Cancers: Results from a Phase 2 Basket Trial
Mirella Nardo, Camila Braganca Xavier, Bettzy Stephen, et al.
Pediatric Blood & Cancer
|
August 5, 2009
Bilateral gonadoblastoma with dysgerminoma and pilocytic astrocytoma with WT1 GT-IVS9 mutation: A 46 XY phenotypic female with Frasier syndrome
Vivek Subbiah, Vicki Huff, Johannes E A Wolff, et al.
NPJ Precision Oncology
|
May 25, 2023
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma
Blessie Elizabeth Nelson, Neha K Reddy, Jason T Huse, et al.
Oncoscience
|
April 11, 2015
Clinical next generation sequencing of pediatric-type malignancies in adult patients identifies novel somatic aberrations
Jorge Galvez Silva, Fernando F Corrales-Medina, Ossama M Maher, et al.
JCO Precision Oncology
|
April 16, 2025
Safety and Activity of Fibroblast Growth Factor Receptor Inhibitors in Advanced Malignancies: A Pooled Analysis of Early-Phase Clinical Trials
Rafael Grochot, Kroopa Joshi, Antonella Cammarota, et al.
Mayo Clinic Proceedings
|
October 5, 2020
Exclusion of Older Adults in COVID-19 Clinical Trials
Joseph Abi Jaoude, Ramez Kouzy, Molly B El Alam, et al.
Pharmacology & Therapeutics
|
January 12, 2023
RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectives
Alfredo Addeo, Ernesto Miranda-Morales, Petra den Hollander, et al.
Page
of 49
Search research articles
Search
Showing results (211-220 of 487) with videos related to
Sort By:
Page
of 49
Abdominal Radiology (New York)
|
November 24, 2019
Imaging of acute abdomen in cancer patients
Ajaykumar C Morani, Abdelrahman K Hanafy, Leonardo P Marcal, et al.
Molecular Cancer Therapeutics
|
April 15, 2018
Clinical Next-Generation Sequencing for Precision Oncology in Rare Cancers
Roman Groisberg, David S Hong, Jason Roszik, et al.
BMC Medical Education
|
June 5, 2023
Challenges in diagnosis and biomarker testing for RET-altered lung and thyroid cancer care: an international mixed-method study
Patrice Lazure, Anthony Sireci, Vivek Subbiah, et al.
Journal of Immunotherapy and Precision Oncology
|
April 11, 2025
Pembrolizumab in Patients with Advanced Miscellaneous Rare Cancers: Results from a Phase 2 Basket Trial
Mirella Nardo, Camila Braganca Xavier, Bettzy Stephen, et al.
Pediatric Blood & Cancer
|
August 5, 2009
Bilateral gonadoblastoma with dysgerminoma and pilocytic astrocytoma with WT1 GT-IVS9 mutation: A 46 XY phenotypic female with Frasier syndrome
Vivek Subbiah, Vicki Huff, Johannes E A Wolff, et al.
NPJ Precision Oncology
|
May 25, 2023
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma
Blessie Elizabeth Nelson, Neha K Reddy, Jason T Huse, et al.
Oncoscience
|
April 11, 2015
Clinical next generation sequencing of pediatric-type malignancies in adult patients identifies novel somatic aberrations
Jorge Galvez Silva, Fernando F Corrales-Medina, Ossama M Maher, et al.
JCO Precision Oncology
|
April 16, 2025
Safety and Activity of Fibroblast Growth Factor Receptor Inhibitors in Advanced Malignancies: A Pooled Analysis of Early-Phase Clinical Trials
Rafael Grochot, Kroopa Joshi, Antonella Cammarota, et al.
Mayo Clinic Proceedings
|
October 5, 2020
Exclusion of Older Adults in COVID-19 Clinical Trials
Joseph Abi Jaoude, Ramez Kouzy, Molly B El Alam, et al.
Pharmacology & Therapeutics
|
January 12, 2023
RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectives
Alfredo Addeo, Ernesto Miranda-Morales, Petra den Hollander, et al.
Page
of 49